Document:

PROMISSORY
NOTE

    

    
      	
              $258,800

            	
              April
      1, 2008

            

    

    

    FOR VALUE
RECEIVED, American Scientific Resources, Inc., with its primary offices located
at 1112 Weston Road, Unit 278, Weston, FL  33326 (the "Maker"), promises to
pay to the order of Tecnimed srl n company with an address of 12, P.le Cocchi,
21040 Vedano Olona, Italy, (the "Payee"), upon the
terms set forth below, the principal sum of Two Hundred and Fifty Eight
Thousand, Eight Hundred ($258,800) Dollars on the unpaid principal sum
outstanding (the “Note”).

    

    1.           Principal               Maker
shall be required to pay the Payee an amount in cash, wire transfer or check
equal to the principal amount, on or before September 30, 2008.

    

    “Payment of Interest”,
Interest on the unpaid principal balance of t his Note shall accrue at a rate of
Twelve percent (12%) per annum commencing on the Issuance
Date.  Interest shall be computed on the basis of a 365-day year and
actual days elapsed.  Interest shall be paid monthly on or before the
30th
day of the month, for the preceding month forward. If interest in such period is
not paid within ten (10) days of such due date, the provisions of Section 2(b)
herein shall take effect.

    

    2.           Events of
Default.

    

    (a)
"Event of
Default", wherever used herein, means any one of the following events
(whatever the reason and whether it shall be voluntary or involuntary or
effected by operation of law or pursuant to any judgment, decree or order of any
court, or any order, rule or regulation of any administrative or governmental
body):

    

    (i) Any
default in the payment of the principal of this Note, as and when the same shall
become due and payable;

    

    (ii)
Maker shall fail to observe or perform any obligation or shall breach any term
or provision of this Note;

    

     (iii)
Maker shall commence, or there shall be commenced against Maker, a case under
any applicable bankruptcy or insolvency laws as now or hereafter in effect or
any successor thereto, or Maker commences any other proceeding under any
reorganization, arrangement, adjustment of debt, relief of debtors, dissolution,
insolvency or liquidation or similar law of any jurisdiction whether now or
hereafter in effect relating to Maker, or there is commenced against Maker, any
such bankruptcy, insolvency or other proceeding which remains undismissed for a
period of 60 days; or Maker is adjudicated insolvent or bankrupt; or any order
of relief or other order approving any such case or proceeding is entered; or
Maker suffers any appointment of any custodian or the like for it or any
substantial part of its property which continues undischarged or unstayed for a
period of 60 days; or Maker, makes a general assignment for the benefit of
creditors; or Maker, shall fail to pay, or shall state that it is unable to pay,
or shall be unable to pay, its debts generally as they become due; or Maker
shall call a meeting of its creditors with a view to arranging a composition,
adjustment or restructuring of its debts; or Maker shall by any act or failure
to act expressly indicate its consent to, approval of or acquiescence in any of
the foregoing; or any corporate or other action is taken by Maker for the
purpose of effecting any of the foregoing; or

    

    (b) If
any Event of Default occurs, the full principal amount of this Note, shall
become, at the Payee's election, immediately due and payable by
check.  The Payee need not provide and Maker hereby waives any
presentment, demand, protest or other notice of any kind, and the Payee may
immediately and without expiration of any grace period enforce any and all of
its rights and remedies hereunder and all other remedies available to it under
applicable law. Such declaration may be rescinded and annulled by Payee at any
time prior to payment hereunder. No such rescission or annulment shall affect
any subsequent Event of Default or impair any right consequent
thereon.

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

    

    3.           No Waiver of Payee's
Rights. All payments of principal shall be made without setoff, deduction
or counterclaim. No delay or failure on the part of the Payee in exercising any
of its options, powers or rights, nor any partial or single exercise of its
options, powers or rights shall constitute a waiver thereof or of any other
option, power or right, and no waiver on the part of the Payee of any of its
options, powers or rights shall constitute a waiver of any other option, power
or right. Maker hereby waives presentment of payment, protest, and all notices
or demands in connection with the delivery, acceptance, performance, default or
endorsement of this Note. Acceptance by the Payee of less than the full amount
due and payable hereunder shall in no way limit the right of the Payee to
require full payment of all sums due and payable hereunder in accordance with
the terms hereof.

    

    4.                         Modifications. No
term or provision contained herein may be modified, amended or waived except by
written agreement or consent signed by the party to be bound
thereby.

    

    5.           Cumulative Rights and
Remedies; Usury. The rights and remedies of Payee expressed herein are
cumulative and not exclusive of any rights and remedies otherwise available
under this Note or applicable law (including at equity). The election of Payee
to avail itself of any one or more remedies shall not be a bar to any other
available remedies, which Maker agrees Payee may take from time to time. If it
shall be found that any interest due hereunder arising from an Event of Default
shall violate applicable laws governing usury, the applicable rate of interest
due hereunder shall be reduced to the maximum permitted rate of interest under
such law.

    

    6.           Collection
Expenses.            If
Payee shall commence an action or proceeding to enforce this Note, then Maker
shall reimburse Payee for its costs of collection and reasonable attorneys fees
incurred with the investigation, preparation and prosecution of such action or
proceeding.

    

    7.           Severability.  If
any term or provision of this Agreement is held by a court of competent
jurisdiction to be invalid, void, or unenforceable, the remainder of the terms
and provisions set forth herein shall remain in full force and effect and shall
in no way be affected, impaired or invalidated, and the parties hereto shall use
their best efforts to find and employ an alternative means to achieve the same
or substantially the same result as that contemplated by such term or
provision.

    

    8.           Successors and
Assigns. This Note shall be binding upon Maker and its successors and
shall inure to the benefit of the Payee and its successors and assigns. The term
"Payee" as used herein, shall also include any endorsee, assignee or other
holder of this Note.

    

    9.           Lost or Stolen Promissory
Note. If this Note is lost, stolen, mutilated or otherwise destroyed,
Maker shall execute and deliver to the Payee a new promissory note containing
the same terms, and in the same form, as this Note. In such event, Maker may
require the Payee to deliver to Maker an affidavit of lost instrument and
customary indemnity in respect thereof as a condition to the delivery of any
such new promissory note. Any costs incurred pursuant to this paragraph shall be
the responsibility of the Payee.

    

    10.           Due Authorization.
This Note has been duly authorized, executed and delivered by Maker and is the
legal obligation of Maker, enforceable against Maker. Maker has taken all
necessary corporate action, by resolution, and the borrowing by maker hereunder
does not conflict with the Maker’s bylaws or Certificate of
Incorporation.

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    11.           Governing Law. All
questions concerning the construction, validity, enforcement and interpretation
of this Note shall be governed by and construed and enforced in accordance with
the internal laws of the State of New York, without regard to the principles of
conflicts of law thereof. Each of Maker and Payee agree that all legal
proceedings concerning the interpretations, enforcement and defense of this Note
shall be commenced in the Courts of the State of New York, located in New York,
New York, the courts of the United States of America for the District of New
York, and appellate courts from any thereof (the "New York Courts").
Each of Maker and Payee hereby irrevocably submit to the exclusive jurisdiction
of the New York Courts for the adjudication of any dispute hereunder (including
with respect to the enforcement of this Note), and hereby irrevocably waives,
and agrees not to assert in any suit, action or proceeding, any claim that it is
not personally subject to the jurisdiction of any such court, that such suit,
action or proceeding is improper. Each of Maker and Payee hereby irrevocably
waive personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or
certified mail or overnight delivery (with evidence of delivery) to the other at
the address in effect for notices to it under this Note and agrees that such
service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right
to serve process in any manner permitted by law. Each of Maker and Payee hereby
irrevocably waive, to the fullest extent permitted by applicable law, any and
all right to trial by jury in any legal proceeding arising out of or relating to
this Note or the transactions contemplated hereby.

    

    12.           Pre-Payment.   Maker
may prepay this Note in whole or in part at any time, and from time to time,
without being required to pay any penalty or premium for such privilege. The
undersigned signs this Note as a maker and not as a surety or guarantor or in
any other capacity.

    

    
      
        
          	
                  American
      Scientific Resources, Inc.

                
	 
      
	
                  By:

                	
                    

                
	 
      	
                  Name:

                	
                  Christopher
      F. Tirotta. MD, MBA

                
	 
      	
                  Title:

                	
                  CEO/Chairman
      of the Board

                
	 
      	
                  Date:

                	
                  April
      1, 2008

                

        

      

    

    
      
         

      

      
        3DEBENTURE

    

    THE
SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE
UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF
ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(b) OF
THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS
PROMULGATED THEREUNDER (THE "1933 ACT"), AND RULE 504 OF REGULATION D
PROMULGATED THEREUNDER AND SECTION 551.23(8)(g) OF THE WISCONSIN UNIFOM
SECURITIES LAW.

    

    THE
SECURITIES OFFERED HEREBY ARE OFFERED PURSUANT TO AN EXEMPTION FOR OFFERINGS TO
ACCREDITED INVESTORS ONLY UNDER THE RULES OF THE WISCONSIN DEPARTMENT OF
FINANCIAL INSTITUTIONS, SECURITIES DIVISION.  THE WISCONSIN DEPARTMENT
OF FINANCIAL INSTITUTIONS, SECURITIES DIVISION, HAS NEITHER REVIEWED NOR
APPROVED ITS FORM OR CONTENT.  THE SECURITIES DESCRIBED HEREIN MAY
ONLY BE PURCHASED BY "ACCREDITED INVESTORS" AS DEFINED BY RULE 504 OF SEC
REGULATION D AND THE RULES OF THE WISCONSIN DEPARTMENT OF FINANCIAL
INSTITUTIONS, SECURITIES DIVISION.

    

    
      	
              Series
      A-2

            	
              US
      $15,000

            

    

    

    AMERICAN
SCIENTIFIC RESOURCES, INC.

    

    8%
CONVERTIBLE REDEEMABLE DEBENTURE

    DUE JULY
3, 2010

    

    THIS DEBENTURE of American Scientific
Resources, Inc. ("Company"), designated
as its Series A 8% Convertible Redeemable Debenture Due July 3,
2010.

    

    
      
         

      

      
        
        

        
          

        

      

      
         

      

    

    FOR VALUE RECEIVED, the Company
promises to pay to The Tripod Group, LLC and its authorized successors and
permitted assigns ("Holder"), the
aggregate principal face amount of fifteen thousand dollars (U.S. $15,000) on
July 3, 2010 ("Maturity Date") and
to pay interest on the principal amount outstanding hereunder at the rate of 8%
per annum commencing on August 3, 2008.  Interest will be paid to the
Holder in whose name this Debenture is registered on the records of the Company
regarding registration and transfers of this Debenture ("Debenture Register");
provided, however, that the Company's obligation to a transferee of this
Debenture arises only if such transfer, sale or other disposition is made in
accordance with the terms and conditions of the Securities Sale Agreement dated
as of March 18, 2008 between the Company and the Holder ("Sale
Agreement").  The principal of, and interest on, this Debenture
are payable at 250 E. Wisconsin Ave., Suite 1800, Milwaukee, WI
53202  initially, and if changed, last appearing on the Debenture
Register of the Company as designated in writing by the Holder hereof from time
to time.  The Company will pay the outstanding principal due upon this
Debenture before or on the Maturity Date, less any amounts required by law to be
deducted or withheld, to the Holder of this Debenture by check if paid more than
10 days prior to the Maturity Date or, if paid 10 days or less prior to the
Maturity Date, by wire transfer and addressed to such Holder at the last address
appearing on the Debenture Register.  The forwarding of such check or
wire transfer shall constitute a payment of outstanding principal hereunder and
shall satisfy and discharge the liability for principal on this Debenture to the
extent of the sum represented by such check or wire
transfer.  Interest shall be payable in Common Stock (as defined
below) pursuant to paragraph 4(b) herein.

    

    This
Debenture is issued pursuant to the Sale Agreement and the Company hereby
confirms that all of the representations and warranties of the Company set forth
in the Sale Agreement are true and correct as of the date hereof, except that
approximately 151,739,928 shares of Common Stock are issued and outstanding,
approximately 35,511,462 of which are free trading and approximately 116,228,466
of which are restricted.

    

    This Debenture is subject to the
following additional provisions:

    

    1.           This
Debenture is issuable or assignable to a Holder in denominations of Five
Thousand Dollars (US$5,000) and integral multiples thereof.  This
Debenture is exchangeable for an equal aggregate principal amount of Debentures
of different authorized denominations, as requested by the Holders surrendering
the same, but not less than U.S. $5,000.  No service charge will be
made for such registration or transfer or exchange, except that Holder shall pay
any tax or other governmental charges payable in connection
therewith.

    

    2.           The
Company shall be entitled to withhold from all payments any amounts required to
be withheld under applicable laws.

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    3.           This
Debenture may be transferred or exchanged only in compliance with the Securities
Act of 1933, as amended ("Act") and applicable
state securities laws and only to an Accredited Investor who resides in
Wisconsin.  Any attempted transfer to a non-qualifying party shall be
treated by the Company as void.  Prior to due presentment for transfer
of this Debenture, the Company and any agent of the Company may treat the person
in whose name this Debenture is duly registered on the Company's Debenture
Register as the owner hereof for all other purposes, whether or not this
Debenture be overdue, and neither the Company nor any such agent shall be
affected or bound by notice to the contrary.  Any Holder of this
Debenture electing to exercise the right of conversion set forth in Section 4(a)
hereof, in addition to the requirements set forth in Section 4(a), and any
prospective transferee of this Debenture, are also required to give the Company
written confirmation that this Debenture is being converted ("Notice of
Conversion"). The date of receipt (including receipt by telecopy) of such
Notice of Conversion shall be the Conversion Date.

    

    4.           (a)           The
Holder of this Debenture is entitled, at its option, at any time following
delivery of this Debenture, to convert all or any
amount over $100 of the principal face amount of this Debenture then outstanding
into shares of the Company's common stock (the "Common Stock")
without restrictive legend of any nature, at a conversion price ("Conversion Price")
for each share of Common Stock equal to 60% of the lowest closing bid price of
the Common Stock as reported on the National Quotations Bureau Pink Sheets on
which the Company’s shares are traded or any exchange upon which the Common
Stock may be traded in the future ("Exchange") for (i)
any of the three trading days prior to the day upon which a Notice of Conversion
is received by the Company, provided such Notice of Conversion is delivered by
fax to the Company between the hours of 4 P.M. Eastern Standard or Daylight
Savings Time and 7 P.M. Eastern Standard or Daylight Savings Time, or (ii) the
trading day on which a Notice of Conversion is received by the Company provided
such Notice of Conversion is delivered by fax to the Company between the hours
of 4 P.M. Eastern Standard or Daylight Savings Time and 7 P.M. Eastern Standard
or Daylight Savings Time.  If the number of resultant shares of Common
Stock would as a matter of law or pursuant to regulatory authority require the
Company to seek shareholder approval of such issuance, the Company shall, as
soon as practicable, take the necessary steps to seek such
approval.  Such conversion shall be effectuated by the Company
delivering the shares of Common Stock to the Holder within 3 business days of
receipt by the Company of the Notice of Conversion.  Once the Holder
has received such shares of Common Stock, the Holder shall surrender this
Debentures to the Company, executed by the Holder evidencing such Holder's
intention to convert this Debenture or a specified portion hereof, and
accompanied by proper assignment hereof in blank.  Accrued but unpaid
interest shall be subject to conversion.  No fractional shares or
scrip representing fractions of shares will be issued on conversion, but the
number of shares issuable shall be rounded to the nearest whole
share.

    

    (b)           Interest
on any unpaid principal balance of this Debenture shall be paid at the rate of
8% per annum.  Interest shall be paid by the Company in Common Stock
("Interest Shares").  The Holder may, at any time, send in a Notice of
Conversion to the Company for Interest Shares based on the formula provided in
Section 4(a) above.  The dollar amount converted into Interest Shares
shall be all or a portion of the accrued interest calculated on the unpaid
principal balance of this Debenture to the date of such
notice.  Interest Shares shall be issued under the exemption from
registration provided by Rule 504 of Regulation D.

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    

    (c)           At
any time the Company shall have the option to redeem this Debenture and pay to
the Holder 150% of the unpaid principal amount of this Debenture, in full. The
Company shall give the Holder 5 days written notice and the Holder during such 5
days shall have the option to convert this Debenture or any part thereof into
shares of Common Stock at the Conversion Price set forth in paragraph 4(a) of
this Debenture.

    

    (d)           Upon
(i) a transfer of all or substantially all of the assets of the Company to any
person in a single transaction or series of related transactions, (ii) a
reclassification, capital reorganization or other change or exchange of
outstanding shares of the Common Stock, or (iii) any consolidation or merger of
the Company with or into another person or entity in which the Company is not
the surviving entity (other than a merger which is effected solely to change the
jurisdiction of incorporation of the Company and results in a reclassification,
conversion or exchange of outstanding shares of Common Stock solely into shares
of Common Stock) (each of items (i), (ii) and (iii) being referred to as a "Sale
Event"), then, in each case, the Company shall, upon request of the Holder,
redeem this Debenture in cash for 150% of the principal amount, plus accrued but
unpaid interest through the date of redemption, or at the election of the
Holder, such Holder may convert the unpaid principal amount of this Debenture
(together with the amount of accrued but unpaid interest) into shares of Common
Stock immediately prior to such Sale Event at the Conversion Price.

    

    (e)           In
case of any Sale Event in connection with which this Debenture is not redeemed
or converted, the Company shall cause effective provision to be made so that the
Holder of this Debenture shall have the right thereafter, by converting this
Debenture, to purchase or convert this Debenture into the kind and number of
shares of stock or other securities or property (including cash) receivable upon
such reclassification, capital reorganization or other change, consolidation or
merger by a holder of the number of shares of Common Stock that could have been
purchased upon exercise of the Debentures and at the same Conversion Price, as
defined in this Debenture, immediately prior to such Sale Event. The foregoing
provisions shall similarly apply to successive Sale Events. If the consideration
received by the holders of Common Stock is other than cash, the value shall be
as determined by the Board of Directors of the Company or successor person or
entity acting in good faith.

    

    5.           No
provision of this Debenture shall alter or impair the obligation of the Company,
which is absolute and unconditional, to pay the principal of, and interest on,
this Debenture at the time, place, and rate, and in the form, herein
prescribed.

    

    6.           The
Company hereby expressly waives demand and presentment for payment, notice of
non-payment, protest, notice of protest, notice of dishonor, notice of
acceleration or intent to accelerate, and diligence in taking any action to
collect amounts called for hereunder and shall be directly and primarily liable
for the payment of all sums owing and to be owing hereto.

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    

    7.           The
Company agrees to pay all costs and expenses, including reasonable attorneys'
fees, which may be incurred by the Holder in collecting any amount due under
this Debenture.

    

    8.           If
one or more of the following described "Events of Default" shall occur and
continue for 30 days, unless a different time frame is noted below:

    

    (a)           The
Company shall default in the payment of principal or interest on this Debenture
or any other debenture issued pursuant to the Sale Agreement; or

    

    (b)           Any
of the representations or warranties made by the Company herein, in the Sale
Agreement, or in any certificate or financial or other written statements
heretofore or hereafter furnished by or on behalf of the Company in connection
with the execution and delivery of this Debenture or the Sale Agreement shall be
false or misleading in any material respect at the time made or the Company
shall violate any covenants in the Sale Agreement including but not limited to
Section 5(b) or 10; or

    

    (c)           The
Company shall fail to perform or observe, in any material respect, any other
covenant, term, provision, condition, agreement or obligation of the Company
under this Debenture or the Sale Agreement  and such failure shall
continue uncured for a period of thirty (30) days after notice from the Holder
of such failure; or

    

    (d)           The
Company shall (1) become insolvent; (2) admit in writing its inability to pay
its debts generally as they mature; (3) make an assignment for the benefit of
creditors or commence proceedings for its dissolution; (4) apply for or consent
to the appointment of a trustee, liquidator or receiver for its or for a
substantial part of its property or business; (5) file a petition
for  bankruptcy relief, consent to the filing of such petition or have
filed against it an involuntary petition for bankruptcy relief, all under
federal or state laws as applicable; or

    

    (e)           A
trustee, liquidator or receiver shall be appointed for the Company or for a
substantial part of its property or business without its consent and shall not
be discharged within thirty (30) days after such appointment; or

    

    (f)           Any
governmental agency or any court of competent jurisdiction at the instance of
any governmental agency shall assume custody or control of the whole or any
substantial portion of the properties or assets of the Company; or

    

    (g)           One
or more money judgments, writs or warrants of attachment, or similar process, in
excess of One Hundred Thousand Dollars ($100,000) in the aggregate, shall be
entered or filed against the Company or any of its properties or other assets
and shall remain unpaid, unvacated, unbonded or unstayed for a period of fifteen
(15) days or in any event later than five (5) days prior to the date of any
proposed sale thereunder; or

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    

    (h)           Bankruptcy,
reorganization, insolvency or liquidation proceedings, or other proceedings for
relief under any bankruptcy law or any law for the relief of debtors shall be
instituted voluntarily by or involuntarily against the Company; or

    

    (i)           If
listed, the Company shall have its Common Stock delisted from an Exchange or, if
the Common Stock trades on an Exchange, then trading in the Common Stock shall
be suspended for more than 10 consecutive days; or

    

    (j)           The
Company shall not deliver to the Holder the Common Stock pursuant to paragraph 4
herein without restrictive legend within 5 business days of its receipt of a
Notice of Conversion.

    

    Then, or
at any time thereafter, unless cured, and in each and every such case, unless
such Event of Default shall have been waived in writing by the Holder (which
waiver shall not be deemed to be a waiver of any subsequent default) at the
option of the Holder and in the Holder's sole discretion, the Holder may
consider this Debenture immediately due and payable, without presentment,
demand, protest or (further) notice of any kind (other than notice of
acceleration), all of which are hereby expressly waived, anything herein or in
any note or other instruments contained to the contrary notwithstanding, and the
Holder may immediately, and without expiration of any period of grace, enforce
any and all of the Holder's rights and remedies provided herein or any other
rights or remedies afforded by law.  Upon an Event of Default,
interest shall be accrue at a default interest rate of 24% per annum or, if such
rate is usurious or not permitted by current law, then at the highest rate of
interest permitted by law.

    

    9.           This
Debenture represents a prioritized obligation of the
Company.  However, no recourse shall be had for the payment of the
principal of, or the interest on, this Debenture, or for any claim based hereon,
or otherwise in respect hereof, against any incorporator, shareholder, officer
or director, as such, past, present or future, of the Company or any successor
corporation, whether by virtue of any constitution, statute or rule of law, or
by the enforcement of any assessment or penalty or otherwise, all such liability
being, by the acceptance hereof and as part of the consideration for the
issuance hereof, expressly waived and released.

    

    10.           In
case any provision of this Debenture is held by a court of competent
jurisdiction to be excessive in scope or otherwise invalid or unenforceable,
such provision shall be adjusted rather than voided, if possible, so that it is
enforceable to the maximum extent possible, and the validity and enforceability
of the remaining provisions of this Debenture will not in any way be affected or
impaired thereby.

    

    11.           This
Debenture and the agreements referred to in this Debenture constitute the full
and entire understanding and agreement between the Company and the Holder with
respect to the subject matter hereof.  Neither this Debenture nor any
term hereof may be amended, waived, discharged or terminated other than by a
written instrument signed by the Company and the Holder.

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

    

    12.           This
Debenture shall be governed by and construed in accordance with the laws of
Wisconsin applicable to contracts made and wholly to be performed within the
State of Wisconsin and shall be binding upon the successors and assigns of each
party hereto.  The Holder and the Company hereby mutually waive trial
by jury and consent to exclusive jurisdiction and venue in the courts of the
State of Wisconsin.  This Agreement may be executed in counterparts,
and the facsimile transmission of an executed counterpart to this Agreement
shall be effective as an original.

    

    {REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK}

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

    IN WITNESS WHEREOF, the Company has
caused this Debenture to be duly executed by an officer thereunto duly
authorized.

    

    Dated:  July
3, 2008

    

    
      
        
          
            
              
                
                  
                    	
                            AMERICAN
      SCIENTIFIC RESOURCES, INC.

                          
	 
      	 
      
	 
      	 
      
	
                            By:

                          	
                            

                          
	
                            Name:  Christopher
      F. Tirotta, MD, MBA

                          
	
                            Title:  CEO/Chairman
      of the
Board

                          

                  

                

              

            

          

        

      

    

     

    
      
        
        

      

      
        8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}]]